Compound Edaravone Injection for Acute Ischemic Stroke, a Multi-center, Randomized, Double-blind, Parallel, and Active-controlled Phase III Trial
Phase of Trial: Phase III
Latest Information Update: 19 Jan 2017
At a glance
- Drugs Borneol/edaravone (Primary) ; Edaravone
- Indications Stroke
- Focus Registrational; Therapeutic Use
- Sponsors Jiangsu Simcere Pharmaceutical
- 12 Jan 2017 Status changed from active, no longer recruiting to completed.
- 30 Nov 2016 Planned primary completion date changed from 1 Oct 2016 to 1 Dec 2016.
- 19 Apr 2016 Planned End Date changed from 1 Oct 2016 to 1 Dec 2016.